Nephropathy
Showing 1 - 25 of 2,557
T- and B-Cell Subpopulations in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- +2 more
-
Istanbul, TurkeyIstanbul University
May 31, 2023
IgA Nephropathy, Immunoglobulin A Nephropathy Trial (BION-1301, Placebo)
Not yet recruiting
- IgA Nephropathy
- Immunoglobulin A Nephropathy
- BION-1301
- Placebo
- (no location specified)
May 2, 2023
Idiopathic Membranous Nephropathy
Not yet recruiting
- Idiopathic Membranous Nephropathy
- Obinutuzumab Injection
- (no location specified)
May 8, 2023
Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of
Active, not recruiting
- Diabetic Nephropathy
- Grouping based on previous laboratory results, no intervention.
-
Jinan, Shandong, ChinaQianfoshan Hospital
Oct 24, 2023
Coronary Artery Disease, Nephropathy; Toxic, Drugs Trial (Atorvastatin 80mg, N-acetyl cysteine, Normal Saline)
Not yet recruiting
- Coronary Artery Disease
- Nephropathy; Toxic, Drugs
- Atorvastatin 80mg
- +2 more
- (no location specified)
Nov 15, 2023
Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)
Not yet recruiting
- Primary Membranous Nephropathy
- (no location specified)
May 16, 2023
Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy Trial (Huaier granule, Renin-angiotensin-aldosterone system
Not yet recruiting
- Nephropathy
- +2 more
- Huaier granule
- +2 more
- (no location specified)
Apr 20, 2023
IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)
Not yet recruiting
- IgA Nephropathy
- Immunoglobulin A Nephropathy
- Atrasentan
- Placebo
- (no location specified)
Apr 27, 2023
IgA Nephropathy Trial (CM338)
Not yet recruiting
- IgA Nephropathy
- CM338
- (no location specified)
Mar 7, 2023
Primary IgA Nephropathy Trial (SHR-2010 Injection, Placebo)
Not yet recruiting
- Primary IgA Nephropathy
- SHR-2010 Injection
- Placebo
- (no location specified)
Apr 27, 2023
Chronic Allograft Nephropathy Trial in Cairo (Elastography arm)
Completed
- Chronic Allograft Nephropathy
- Elastography arm
-
Cairo, EgyptCairo university hospitals
Dec 27, 2022
Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)
Not yet recruiting
- Membranous Nephropathy
- Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
-
Nice, FranceCHU de NICE
Jul 4, 2023
Technology and Clinical Transformation of Type 2 Diabetes
Recruiting
- Diabetic Nephropathy Type 2
- +2 more
-
Beijing, ChinaChinese PLA General Hospital
May 25, 2023
Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)
Completed
- Type 1 Diabetic Nephropathy
- oral sitagliptin supplementation
-
Cairo, EgyptNancy Elbarbary
Nov 2, 2023
CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy
Not yet recruiting
- Type 2 DM /Diabetic Nephropathy
- (no location specified)
Jan 28, 2023
Idiopathic Membranous Nephropathy Trial in Beijing (Rituximab, Modified Ponticelli regimen)
Recruiting
- Idiopathic Membranous Nephropathy
- Rituximab
- Modified Ponticelli regimen
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 23, 2023
Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease
Recruiting
- Fabry Disease
-
Rockville, Maryland
- +1 more
Sep 29, 2023
Diabetes Complications, Diabetes; Nephropathy (Manifestation) Trial in Stockholm (Roxadustat, Darbepoietin Alfa)
Not yet recruiting
- Diabetes Complications
- Diabetes; Nephropathy (Manifestation)
- Roxadustat
- Darbepoietin Alfa
-
Stockholm, SwedenCentre for diabetes
Apr 11, 2023
Diabetic Nephropathy Type 2 Trial (Acetylsalicylic Acid, Placebo)
Not yet recruiting
- Diabetic Nephropathy Type 2
- Acetylsalicylic Acid
- Placebo
- (no location specified)
Sep 28, 2023
Membranous Nephropathy - PLA2R Induced Trial in Saint Petersburg (Rituximab, Cyclophosphamide, and Corticosteroids)
Recruiting
- Membranous Nephropathy - PLA2R Induced
- Rituximab, Cyclophosphamide, and Corticosteroids
-
Saint Petersburg, Russian FederationSt. Petersburg State Pavlov Medical University
Jan 7, 2023
Predictive Value of Osteopontin for Contrast Nephropathy
Not yet recruiting
- Contrast-induced Nephropathy
- (no location specified)
Sep 19, 2022
Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)
Not yet recruiting
- Primary Membranous Nephropathy
- (no location specified)
Jan 23, 2023